Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways
- PMID: 24127286
- DOI: 10.1002/mc.22092
Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways
Abstract
Silymarin has been known as a chemopreventive agent, and possesses multiple anti-cancer activities including induction of apoptosis, inhibition of proliferation and growth, and blockade of migration and invasion. However, whether silymarin could inhibit prostaglandin (PG) E2 -induced renal cell carcinoma (RCC) migration and what are the underlying mechanisms are not well elucidated. Here, we found that silymarin markedly inhibited PGE2 -stimulated migration. PGE2 induced G protein-dependent CREB phosphorylation via protein kinase A (PKA) signaling, and PKA inhibitor (H89) inhibited PGE2 -mediated migration. Silymarin reduced PGE2 -induced CREB phosphorylation and CRE-promoter activity. PGE2 also activated G protien-independent signaling pathways (Src and STAT3) and silymarin reduced PGE2 -induced phosphorylation of Src and STAT3. Inhibitor of Src (Saracatinib) markedly reduced PGE2 -mediated migration. We found that EP2, a PGE2 receptor, is involved in PGE2 -mediated cell migration. Down regulation of EP2 by EP2 siRNA and EP2 antagonist (AH6809) reduced PGE2 -inudced migration. In contrast, EP2 agonist (Butaprost) increased cell migration and silymarin effectively reduced butaprost-mediated cell migration. Moreover, PGE2 increased EP2 expression through activation of positive feedback mechanism, and PGE2 -induced EP2 expression, as well as basal EP2 levels, were reduced in silymarin-treated cells. Taken together, our study demonstrates that silymarin inhibited PGE2 -induced cell migration through inhibition of EP2 signaling pathways (G protein dependent PKA-CREB and G protein-independent Src-STAT3).
Keywords: EP2; PGE2; migration; renal carcinoma; silymarin.
© 2013 Wiley Periodicals, Inc.
Similar articles
-
The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.J Biol Chem. 2010 Dec 17;285(51):39672-81. doi: 10.1074/jbc.M110.117689. Epub 2010 Oct 19. J Biol Chem. 2010. PMID: 20959465 Free PMC article.
-
PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling.Am J Physiol Cell Physiol. 2009 Jan;296(1):C75-87. doi: 10.1152/ajpcell.00024.2008. Epub 2008 Nov 12. Am J Physiol Cell Physiol. 2009. PMID: 19005164
-
Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.Am J Rhinol Allergy. 2014 May-Jun;28(3):e120-4. doi: 10.2500/ajra.2014.28.4039. Am J Rhinol Allergy. 2014. PMID: 24980222
-
Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review).Int J Mol Med. 2018 Sep;42(3):1203-1214. doi: 10.3892/ijmm.2018.3744. Epub 2018 Jun 26. Int J Mol Med. 2018. PMID: 29956743 Review.
-
Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.Trends Pharmacol Sci. 2013 Jul;34(7):413-23. doi: 10.1016/j.tips.2013.05.003. Epub 2013 Jun 21. Trends Pharmacol Sci. 2013. PMID: 23796953 Free PMC article. Review.
Cited by
-
Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.Cancer Res. 2022 Mar 15;82(6):949-965. doi: 10.1158/0008-5472.CAN-21-2297. Cancer Res. 2022. PMID: 34949672 Free PMC article. Review.
-
Thymoquinone Suppresses Migration of Human Renal Carcinoma Caki-1 Cells through Inhibition of the PGE2-Mediated Activation of the EP2 Receptor Pathway.Biomol Ther (Seoul). 2021 Jan 1;29(1):64-72. doi: 10.4062/biomolther.2020.048. Biomol Ther (Seoul). 2021. PMID: 32843585 Free PMC article.
-
Construction and Validation of a Protein-associated Prognostic Model for Gastrointestinal Cancer.Comb Chem High Throughput Screen. 2023;26(1):191-206. doi: 10.2174/1386207325666220414105743. Comb Chem High Throughput Screen. 2023. PMID: 35430986
-
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X211068826. doi: 10.1177/2515690X211068826. J Evid Based Integr Med. 2022. PMID: 35018864 Free PMC article. Review.
-
Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression.Int J Mol Sci. 2022 Feb 28;23(5):2672. doi: 10.3390/ijms23052672. Int J Mol Sci. 2022. PMID: 35269825 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous